hims novo nordisk - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

Novo Nordisk ends Hims & Hers deal over Wegovy knockoffs

Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss drug.

CBS News on MSN · 3d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Yahoo Finance · 3h

Hims & Hers Health (NYSE:HIMS) Faces Class Action After Partnership Termination With Novo Nordisk

Hims & Hers Health (NYSE:HIMS) has experienced a tumultuous quarter, marked by Novo Nordisk's termination of their collaboration after allegations of unsafe practices, resulting in a 35% drop in the company's share price.

Medical Marketing & Media48m

Novo breaking up with Hims & Hers offers medical marketers a lesson

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

11h

Ozempic-maker Novo Nordisk's shares under growing pressure

Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results